Natera

Sr Translational Med Scientist

United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, PharmaceuticalsIndustries

Senior Translational Medical Scientist

Position Overview

The Senior Translational Medical Scientist plays a key role in advancing Natera’s oncology pipeline by partnering with clinicians, product managers, and key opinion leaders (KOLs) to apply genomic data in improving healthcare outcomes. This role primarily supports the development of products for early cancer detection, with secondary responsibilities that include participation in translational initiatives aimed at optimizing circulating tumor DNA (ctDNA) testing and informing clinical decision-making in both solid and hematologic malignancies. This is a highly collaborative, cross-functional role requiring regular interaction with internal stakeholders as well as external research partners, pharmaceutical collaborators, and academic leaders. The Senior Translational Medical Scientist will contribute across multiple high-impact projects in a fast-paced, evolving environment.

Location Type: [Not Specified] Employment Type: [Not Specified] Salary: [Not Specified]

Primary Responsibilities

  • Partner with R&D teams, clinicians, product managers, and KOLs to identify specimen biobanks to support early cancer detection assay development.
  • Apply expertise in genomics, molecular biology, and cancer biology to evaluate research and commercial opportunities in early cancer detection.
  • Collaborate with molecular biologists, computational biologists, and statisticians to develop and execute innovative research strategies.
  • Perform genomic analyses to investigate biological and clinical questions in oncology, with a focus on translating findings into improved patient care.
  • Lead internal efforts related to oncology knowledge management and curation.
  • Collaborate with external partners including academic KOLs, biotech firms, and pharmaceutical companies.
  • Communicate research findings to external collaborators and contribute to publications in high-impact journals.
  • Provide guidance and oversight to scientists and research associates.
  • Support the Regulatory Affairs team by assisting with responses to CLIA, CAP, and FDA inquiries related to product design and validation.

Compliance & PHI Responsibilities

  • Regularly works with protected health information (PHI) in both electronic and paper formats.
  • Must complete HIPAA/PHI privacy training, General Policies and Procedures, and security training within the first 30 days of hire.
  • Must maintain up-to-date training and compliance per Natera’s internal standards.

Qualifications

  • Education: Ph.D. in Molecular Biology, Genomics, Cancer Biology, Genetics, or related field required.
  • Experience: Minimum of 5-8 years of relevant experience in translational science, oncology, or related fields.

Knowledge, Skills & Abilities

  • Deep scientific background in oncology.
  • Experience with circulating nucleic acids and early cancer detection methods (e.g., methylation, SNV/indel panels, fragmentation) strongly preferred.
  • Familiarity with the use and optimization of novel genomic technologies and awareness of the competitive landscape.

Skills

Genomics
Molecular Biology
Cancer Biology
ctDNA Testing
Oncology
Translational Research
Assay Development
Biobanking
Data Analysis
Clinical Decision-Making
Research Strategy
Knowledge Management
Publication
Collaboration

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI